ilmscore | Prediction Details
"growth isn't quite as high as some of the other drug Discovery stocks with Revenue expected up 10% this year and next"
By Let's Talk Money! with Joseph Hogue, CFA | June 14, 2024 | Pending
From video
7 AI Stocks to Buy Revolutionizing Healthcare 00:14:03 - 00:14:07
Interpreted Prediction
Certara (CERT) is expected to have revenue growth of 10% in 2024 and 2025.

Prediction Details

Ticker
CERT
Initial Price
14.89 USD

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.